These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37486445)

  • 41. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
    Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
    Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines.
    Ladabaum U; Shepard J; Mannalithara A
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2895-2904.e4. PubMed ID: 35580769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fecal DNA Testing for Colorectal Cancer Screening.
    Carethers JM
    Annu Rev Med; 2020 Jan; 71():59-69. PubMed ID: 31451044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colonoscopy after a Positive Stool-based Test for Colon Cancer Screening: Moving Toward a Better Understanding of What to Expect.
    Krigel A; Wan DW
    Cancer Prev Res (Phila); 2022 Jul; 15(7):417-418. PubMed ID: 35788831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing.
    Cooper GS; Grimes A; Werner J; Cao S; Fu P; Stange KC
    J Am Board Fam Med; 2021; 34(1):61-69. PubMed ID: 33452083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract Radiotherapy.
    Ebner DW; Eckmann JD; Burger KN; Mahoney DW; Whitaker TJ; Petersen IA; Kisiel JB
    Gastro Hep Adv; 2022; 1(5):746-754. PubMed ID: 36117548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial.
    Hurt C; Ramaraj R; Farr A; Morgan M; Williams N; Philips CJ; Williams GT; Gardner G; Porter C; Sampson J; Hillier S; Heard H; Dolwani S;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):364-375. PubMed ID: 30885505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy.
    Barclay RL; Vicari JJ; Doughty AS; Johanson JF; Greenlaw RL
    N Engl J Med; 2006 Dec; 355(24):2533-41. PubMed ID: 17167136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
    Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening.
    Yang C; Wu W; Yang Y; Yang X; Sun J; Zhang W; Liu K; Ying H; Jiang S; Yu X; Shi Y; Zhou Y; Zhu S; Xu Y; Ding Y; Xie L; Cai B; Xin X; Chen P; Zhao R; Wu Y
    Oncol Lett; 2020 Aug; 20(2):1193-1200. PubMed ID: 32724359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
    Berger BM; Schroy PC; Dinh TA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.
    Anderson JC; Butterly LF; Weiss JE; Robinson CM
    Gastrointest Endosc; 2017 Jun; 85(6):1188-1194. PubMed ID: 28153571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computer-aided detection versus advanced imaging for detection of colorectal neoplasia: a systematic review and network meta-analysis.
    Spadaccini M; Iannone A; Maselli R; Badalamenti M; Desai M; Chandrasekar VT; Patel HK; Fugazza A; Pellegatta G; Galtieri PA; Lollo G; Carrara S; Anderloni A; Rex DK; Savevski V; Wallace MB; Bhandari P; Roesch T; Gralnek IM; Sharma P; Hassan C; Repici A
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):793-802. PubMed ID: 34363763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inappropriate Ordering of Multitarget Stool DNA Tests for Colon Cancer Screening.
    Ahn AB; Kulhari S; Rhee J; Cooper G
    J Am Board Fam Med; 2024; 37(2):328-331. PubMed ID: 38740492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic Performance of Stool-based Testing for Colorectal Lesions Among Average-risk Individuals: A Real-world Evidence Study.
    Cheney C; Parish A; Niedzwiecki D; Oko C; Walters C; Sullivan BA
    J Clin Gastroenterol; 2024 Aug; ():. PubMed ID: 39083510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study.
    Sekiguchi M; Westerberg M; Ekbom A; Hultcrantz R; Forsberg A
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2120-2130. PubMed ID: 36062316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.
    Cavicchi M; Tharsis G; Burtin P; Cattan P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Karsenti D
    Dig Dis Sci; 2019 Dec; 64(12):3579-3588. PubMed ID: 31471862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lowering the colorectal cancer screening age improves predicted outcomes in a microsimulation model.
    Fisher DA; Saoud L; Finney Rutten LJ; Ozbay AB; Brooks D; Limburg PJ
    Curr Med Res Opin; 2021 Jun; 37(6):1005-1010. PubMed ID: 33769894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.